Table 6 Perceived advantages of licensing use of m-RDT in community pharmacies
Items | Disagree | Agree | Mean (SD) | ||
|---|---|---|---|---|---|
Licensing malaria Rapid diagnostic in community Pharmacies can: | n | % | n | % | |
Prevent long queues of people at public facilities seeking malaria treatment | 27 | 13.5 | 173 | 86.5 | 1.87 (0.34) |
Save people’s time and money by traveling to public health facilities for malaria treatment. | 28 | 14.0 | 172 | 86.0 | 1.86 (0.35) |
Prevent the use of antimalarial medicines without malaria confirmation | 18 | 9.0 | 182 | 91.0 | 1.91 (0.29) |
Reduce the use of malaria medicines for other malaria-like symptoms | 17 | 8.5 | 183 | 91.5 | 1.91 (0.28) |
Increase adherence to the recommended treatment after a test | 19 | 9.5 | 181 | 90.5 | 1.91 (0.29) |
Help patients to find alternative treatment in case of a negative test. | 17 | 8.5 | 183 | 91.5 | 1.92 (0.28) |
Promote rational use of anti-malaria medicines in community Pharmacies. | 17 | 8.5 | 183 | 91.5 | 1.92 (0.28) |
Prevent presumptive treatment of malaria in community Pharmacies | 21 | 10.5 | 179 | 89.5 | 1.90 (0.31) |
Detect early malaria, thus early management. | 27 | 13.5 | 173 | 86.5 | 1.87 (0.34) |
Prevent antimalarial drug resistance. | 23 | 11.5 | 177 | 88.5 | 1.89 (0.32) |